Emergent BioSolutions Inc. announced the anticipated executive management team of Aptevo Therapeutics Inc., Emergent's planned Biosciences business spin-off company. Members of the Aptevo executive management team will be appointed to their positions effective upon completion of the tax-free spin-off of Aptevo, expected to occur in mid-2016. As previously announced, Marvin L. White will serve as Aptevo's Chief Executive Officer upon the expected completion of the spin-off.

He will be joined on the executive management team by the following individuals: Jeff Lamothe, SVP and Chief Financial Officer; Scott C. Stromatt, Chief Medical Officer & SVP, Clinical Development & Medical Affairs; Jane Gross, VP, Research and Non-Clinical Development; Mike Adelman, VP, Commercial Operations; and Shawnte Mitchell, VP and General Counsel. Mr. White is currently a member of Emergent BioSolutions' Board of Directors. He is the former Chief Financial Officer of St.

Vincent's Health. Mr. Lamothe will lead Finance, Business Development, Investor Relations, and IT. He currently serves as Emergent's VP Finance, Biosciences Division.

Mr. Lamothe assumed this role in 2014 when Emergent concluded the acquisition of Cangene Corporation, where he was Chief Financial Officer. Scott C. Stromatt, M.D., Chief Medical Officer and SVP, Clinical Development & Medical Affairs Dr. Stromatt will continue as the Chief Medical Officer at Aptevo. Dr. Gross will continue to lead research and non-clinical development, a position she has held for the last five years at Emergent.

She will lead research efforts in molecular biology and protein engineering, immunology, protein and cell sciences, and translational research for clinical development. Mr. Adelman will continue to lead all commercial functions at Aptevo as VP, Commercial Operations, a position that he has held since 2012 at Cangene Corporation, which was acquired by Emergent in 2014. Ms. Mitchell will lead Governance, SEC, Intellectual Property, Contracts, and Compliance.

She is currently VP, Associate General Counsel and Assistant Secretary of Emergent, where she provides strategic legal advice in a variety of areas, including corporate governance, healthcare regulatory, and product development, and has served as lead negotiator on various transactions.